Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Laredo, TX MSA — October 2026
Laredo life sci pay lags nationally despite a tighter labor market.
Laredo's 4.1% unemployment rate beats the 4.4% Texas average, but Clinical Research Associate pay sits $11,172 below the national median, exposing a retention gap as Texas biopharma postings surge 53% year-over-year.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Laredo unemployment rate: 4.1% — vs 4.4% Texas, 4.1% U.S. national
- CRA pay gap vs national: -$11,172 — Metro $78,893 vs national $90,065 median
- Texas biopharma postings growth: +53% YoY — Jan–Aug 2026, outpacing hiring capacity
- National lab/R&D vacancy rate: 23.2% — Top 13 U.S. life sciences markets, Q1 2026
Key takeaways
Local pay for scientific talent trails the national market by a wide margin.
Research Scientist advertised pay in Laredo sits near $123,070 against a national median of $130,339, and Clinical Research Associate pay shows an even steeper gap ($78,893 versus $90,065). That differential may signal Laredo employers are drawing from a thinner local applicant pool willing to accept below-national compensation, or that roles are being filled by less experienced candidates.
Regulatory Affairs pay is softening locally while national demand stays strong.
Metro Regulatory Affairs Specialist pay fell moderately to $95,473 even as national postings for the role remain among the hardest-to-fill in pharma per industry surveys. A local pay decline against rising national competition for the same skill set suggests Laredo-based employers risk losing regulatory talent to remote opportunities paying national rates.
Biostatistician pay in Laredo now exceeds the national figure.
Metro median Biostatistician pay at $139,166 runs above the $131,958 national median, an unusual inversion for a smaller metro. This may reflect a small, concentrated local sample, and warrants confirming against job order volume before treating it as a market signal.
Low local quit activity nationally is colliding with rising Texas biopharma demand.
National quit rates sitting at 1.9% mean experienced professionals are largely staying put, while Texas biopharma job postings rose 53% year-over-year through August. Laredo employers competing for the same scarce talent pool should expect counteroffers and extended time-to-fill on any specialized requisition this quarter.
Median advertised pay by role — Laredo, TX MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,765 | $123,070 | $131,979 | Significant increase | $130,339 |
| Clinical Research Associate * | $57,977 | $78,893 | $95,462 | Moderate increase | $90,065 |
| Lab Technician * | $38,082 | $45,670 | $49,588 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $70,793 | $95,473 | $116,373 | Moderate decline | $103,780 |
| Clinical Data Manager * | $96,453 | $122,953 | $135,700 | Stable | $123,653 |
| Biostatistician * | $98,485 | $139,166 | $160,691 | Moderate increase | $131,958 |
| Validation Engineer * | $82,756 | $104,143 | $112,977 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Laredo's 4.1% October unemployment rate continues to outperform both Texas (4.4%) and reflects a labor force expanding faster than payroll growth, with the civilian labor force up roughly 2,900 year-over-year even as the metro's life sciences footprint remains thin relative to Houston, Dallas and Austin. Cross-border trade dynamics and Webb County's logistics-heavy employment base mean specialized scientific and clinical talent largely has to be recruited in from outside the metro, a structural condition that predates this month's data but is reinforced by continued low local unemployment.
What it means
Tight overall labor supply in Laredo compounds a national pattern where lab and R&D vacancy sits above 23% and experienced CRAs remain the binding constraint — any life sciences employer with a metro presence is effectively competing against Houston, San Antonio and national remote postings for the same scarce regulatory, clinical and quality talent, a competitive set distinct from the local general labor pool. Build-vs-outsource calculus should weight the near-impossibility of local sourcing for CMC, biomanufacturing or regulatory affairs roles against CRO/CDMO capacity, particularly as Texas regulatory affairs advertised pay has softened even while national demand for the role stays elevated. Organizations should evaluate whether Laredo-based roles requiring deep scientific or regulatory credentials are better structured as remote/hybrid postings benchmarked to national pay levels.
Looking ahead
Early indicator: Watch whether Laredo's Regulatory Affairs Specialist pay decline persists into November data or reverses, since a continued slide against rising national demand would widen the gap employers must close to retain compliance talent.
Worth watching: Texas Medical and Health Biological Science employment grew 14.7% statewide; track whether any of that growth materializes in Webb County payroll data or remains concentrated in Houston, Dallas and Austin.
Potential inflection point: National CRA and clinical operations vacancies remain the top hiring bottleneck in biopharma; Laredo employers relying on CRO partnerships should monitor whether CDMO/CRO capacity tightens further, which would push build-vs-outsource decisions toward in-house hiring despite the local talent scarcity.
Expected: Texas Workforce Commission's full October metro-level release (due mid-November) will confirm whether Laredo's labor force growth is outpacing employment growth, a dynamic that typically precedes wage softening if it continues.
Sources
- Texas Workforce Commission — Laredo MSA unemployment rate was 4.1% in October 2026
- Life sciences labor market research notes — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets in Q1 2026
- Biopharma industry hiring survey — National quit rate sits at 1.9%, indicating experienced professionals are staying in place
- Texas life sciences labor market research — Texas biopharma job postings surged 53% YoY Jan–Aug 2026
- Texas life sciences labor market research — Texas Medical and Health Biological Science positions grew 14.7%, median pay $84,114
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.